Other Species / Isoforms
  EFNB1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y79-p
PYEYYKLyLVRPEQA
0 1
EFNB1 (human) PYEYYKLyLVRPEQA Y79-p
EFNB1 (mouse) PYEYYKLYLVRPEQA Y79
EFNB1 (rat) PYEYYKLYLVRPEQA Y79
EFNB1 (chicken) PYDYYKLYLVKKDQA Y75
N139
YYITSTSNGSLEGLE
0 1
EFNB1 (human) YYITSTSNGSLEGLE N139
EFNB1 (mouse) YYITSTSnGSLEGLE N139-ng
EFNB1 (rat) YYITSTSNGSLEGLE N139
EFNB1 (chicken) YFITSTSNGTLDGLE N135
K163-ub
RTMKIIMkVGQDPNA
0 1
EFNB1 (human) RTMKIIMkVGQDPNA K163-ub
EFNB1 (mouse) RTMKIVMKVGQDPNA K163
EFNB1 (rat) RTMKIVMKVGQDPNA K163
EFNB1 (chicken) RSMKIVMKVGQDPNA K159
T172-ga
GQDPNAVtPEQLtts
0 1
EFNB1 (human) GQDPNAVtPEQLtts T172-ga
EFNB1 (mouse) GQDPNAVTPEQLTTS T172
EFNB1 (rat) GQDPNAVTPEQLTTS T172
EFNB1 (chicken) GQDPNAVIPEQLTTS I168
T177-ga
AVtPEQLttsRPSKE
0 1
EFNB1 (human) AVtPEQLttsRPSKE T177-ga
EFNB1 (mouse) AVTPEQLTTSRPSKE T177
EFNB1 (rat) AVTPEQLTTSRPSKE T177
EFNB1 (chicken) AVIPEQLTTSRPSKE T173
T178-ga
VtPEQLttsRPSKEA
0 1
EFNB1 (human) VtPEQLttsRPSKEA T178-ga
EFNB1 (mouse) VTPEQLTTSRPSKES T178
EFNB1 (rat) VTPEQLTTSRPSKES T178
EFNB1 (chicken) VIPEQLTTSRPSKEA T174
S179-ga
tPEQLttsRPSKEAD
0 1
EFNB1 (human) tPEQLttsRPSKEAD S179-ga
EFNB1 (mouse) TPEQLTTSRPSKESD S179
EFNB1 (rat) TPEQLTTSRPSKESD S179
EFNB1 (chicken) IPEQLTTSRPSKEAD S175
T188-ga
PSKEADNtVKMATQA
0 1
EFNB1 (human) PSKEADNtVKMATQA T188-ga
EFNB1 (mouse) PSKESDNTVKTATQA T188
EFNB1 (rat) PSKESDNTVKTATQA T188
EFNB1 (chicken) PSKEADNTVKIVTQS T184
S201-ga
QAPGSRGsLGDSDGK
0 1
EFNB1 (human) QAPGSRGsLGDSDGK S201-ga
EFNB1 (mouse) TQAPGRGSQGDSDGK S200
EFNB1 (rat) TQAPGRGSQGDSDGK S200
EFNB1 (chicken) QSPRHKVPTVEEPGK P197
T211-ga
DSDGKHEtVNQEEKs
0 1
EFNB1 (human) DSDGKHEtVNQEEKs T211-ga
EFNB1 (mouse) DSDGKHETVNQEEKS T210
EFNB1 (rat) DSDGKHETVNQQEKS T210
EFNB1 (chicken) EEPGKPGSVNQNGQE S207
S218-p
tVNQEEKsGPGAsGG
0 1
EFNB1 (human) tVNQEEKsGPGAsGG S218-p
EFNB1 (mouse) TVNQEEKSGPGAGGG S217
EFNB1 (rat) TVNQQEKSGPGAGGS S217
EFNB1 (chicken) NQNGQETQGPSDGFL Q216
S223-p
EKsGPGAsGGssGDP
0 1
EFNB1 (human) EKsGPGAsGGssGDP S223-p
EFNB1 (mouse) EKSGPGAGGGGSGDS G222
EFNB1 (rat) EKSGPGAGGSGSGDT G222
EFNB1 (chicken) gap -
S226-p
GPGAsGGssGDPDGF
0 1
EFNB1 (human) GPGAsGGssGDPDGF S226-p
EFNB1 (mouse) GPGAGGGGSGDSDSF G225
EFNB1 (rat) GPGAGGSGSGDTDSF G225
EFNB1 (chicken) gap -
S227-p
PGAsGGssGDPDGFF
0 1
EFNB1 (human) PGAsGGssGDPDGFF S227-p
EFNB1 (mouse) PGAGGGGSGDSDSFF S226
EFNB1 (rat) PGAGGSGSGDTDSFF S226
EFNB1 (chicken) gap -
S281-p
QQRAAALsLsTLAsP
Upstream
0 10
Treatment
  • ischemia
EFNB1 (human) QQRAAALsLsTLAsP S281-p
EFNB1 (mouse) QQRAAALsLSTLAsP S280-p
EFNB1 (rat) QQRAAALSLSTLASP S280
EFNB1 (chicken) QQRAAALSLSTLASP S270
S283-p
RAAALsLsTLAsPkG
0 1
EFNB1 (human) RAAALsLsTLAsPkG S283-p
EFNB1 (mouse) RAAALsLSTLAsPkG S282
EFNB1 (rat) RAAALSLSTLASPKG S282
EFNB1 (chicken) RAAALSLSTLASPKC S272
S287-p
LsLsTLAsPkGGSGT
Upstream
0 14
Treatment
  • nocodazole
EFNB1 (human) LsLsTLAsPkGGSGT S287-p
EFNB1 (mouse) LsLSTLAsPkGGSGT S286-p
EFNB1 (rat) LSLSTLASPKGDSGT S286
EFNB1 (chicken) LSLSTLASPKCSGNA S276
K289-ub
LsTLAsPkGGSGTAG
0 10
EFNB1 (human) LsTLAsPkGGSGTAG K289-ub
EFNB1 (mouse) LSTLAsPkGGSGTAG K288-ub
EFNB1 (rat) LSTLASPKGDSGTAG K288
EFNB1 (chicken) LSTLASPKCSGNAGS K278
Y313-p
LRTTENNyCPHyEkV
Upstream
1 136
Treatment
  • ephrin_B1
  • ephrin_B2
  • Su11274
EFNB1 (human) LRTTENNyCPHyEkV Y313-p
EFNB1 (mouse) LRTTENNyCPHyEkV Y312-p
EFNB1 (rat) LRTTENNYCPHYEKV Y312
EFNB1 (chicken) LRTTENNYCPHYEKV Y301
Y317-p
ENNyCPHyEkVsGDy
Upstream
Downstream
2 204
Effects on Biological Processes:
  • cell adhesion, induced
  • signaling pathway regulation
Regulatory protein:
  • Claudin-1 (human)
Treatment
  • ephrin_B1
  • ephrin_B2
  • FGF2
  • PP2
  • Su11274
EFNB1 (human) ENNyCPHyEkVsGDy Y317-p
EFNB1 (mouse) ENNyCPHyEkVsGDy Y316-p
EFNB1 (rat) ENNYCPHYEKVSGDY Y316
EFNB1 (chicken) ENNYCPHYEKVSGDy Y305
K319-ub
NyCPHyEkVsGDyGH
0 2
EFNB1 (human) NyCPHyEkVsGDyGH K319-ub
EFNB1 (mouse) NyCPHyEkVsGDyGH K318-ub
EFNB1 (rat) NYCPHYEKVSGDYGH K318
EFNB1 (chicken) NYCPHYEKVSGDyGH K307
S321-p
CPHyEkVsGDyGHPV
0 17
EFNB1 (human) CPHyEkVsGDyGHPV S321-p
EFNB1 (mouse) CPHyEkVsGDyGHPV S320-p
EFNB1 (rat) CPHYEKVSGDYGHPV S320
EFNB1 (chicken) CPHYEKVSGDyGHPV S309
Y324-p
yEkVsGDyGHPVyIV
Upstream
4 136
EFNB1 (human)
Y324-p
EFNB1 (mouse)
Y323-p
Treatment
  • erlotinib
  • FGF2
  • Su11274
EFNB1 (human) yEkVsGDyGHPVyIV Y324-p
EFNB1 (mouse) yEkVsGDyGHPVyIV Y323-p
EFNB1 (rat) YEKVSGDYGHPVYIV Y323
EFNB1 (chicken) YEKVSGDyGHPVyIV Y312-p
Y329-p
GDyGHPVyIVQEMPP
Upstream
4 130
EFNB1 (human)
Y329-p
EFNB1 (mouse)
Y328-p
Treatment
  • Su11274
EFNB1 (human) GDyGHPVyIVQEMPP Y329-p
EFNB1 (mouse) GDyGHPVyIVQEMPP Y328-p
EFNB1 (rat) GDYGHPVYIVQEMPP Y328
EFNB1 (chicken) GDyGHPVyIVQEMPP Y317-p
Y343-p
PQSPANIyyKV____
Upstream
2 181
Treatment
  • erlotinib
  • gefitinib
  • Su11274
EFNB1 (human) PQSPANIyyKV____ Y343-p
EFNB1 (mouse) PQSPANIyYKV____ Y342-p
EFNB1 (rat) PQSPANIYYKV____ Y342
EFNB1 (chicken) PQSPANIyYKV____ Y331-p
Y344-p
QSPANIyyKV_____
1 35
EFNB1 (human) QSPANIyyKV_____ Y344-p
EFNB1 (mouse) QSPANIyYKV_____ Y343
EFNB1 (rat) QSPANIYYKV_____ Y343
EFNB1 (chicken) QSPANIyYKV_____ Y332